retatrutide safety profile clinical trials A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity How to Get Retatrutide in

Cora Health vs Ro: the short answer Cora Health and Ro (Ro Body) are both US telehealth platforms that connect patients with licensed providers for GLP-1 weight loss treatment, though as of July 2026 they no longer compete in the same medication category Ro fully exited compounded semaglutide and tirzepatide earlier in 2026 and now sells only FDA-approved branded GLP-1s

Why this structure matters to you: You're not buying medication from LIV Body

And the 12 mg group lost 24.2%, compared to just 2.1% in the placebo group

When the trials were stratified according to pathology, RR was 2.29 (95% CI, 1.643.18) in trials focused on people with obesity, near two-fold higher than that observed in trials concerning the treatment of T2D or other diseases (1.27

OTC medications such as loperamide (Imodium) and bismuth subsalicylate (Pepto-Bismol) work to reduce diarrhea

They can also advise if they think starting a GLP-1 will be a good idea, based on your individual medical circumstances